Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 11633471

Compositions and methods for reducing serum triglycerides

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11634404

Selective D3 dopamine receptor agonists and methods of their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11634443

Treprostinil prodrugs

United Therapeutics Corporation · Granted Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11629334

Methods of isolating T cells and T cell receptors having antigenic specificity for a cance

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11623945

Immunostimulating compositions and uses therefore

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11622975

Compositions and methods for improved honey bee health

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11623918

Compounds for the treatment of acute and chronic kidney disease

United States Government as represented by the Department of Veterans Affairs · Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11617753

Methods of treating and inhibiting Ebola virus infection

The United States of America, as represented by the Secretary, Health and Human Services · Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11617800

Nanoparticle-enhanced activity of a potassium channel-blocking peptide

The Government of the United States of America, as represented by the Secretary of the Navy · Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11617801

RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11607426

Method of targeting oncolytic viruses to tumors

United States Government as represented by the Department of Veterans Affairs · Granted Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11602559

HIV-1 Env fusion peptide immunogens and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11591372

Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F p

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11584736

Heterocyclic P2Y14 receptor antagonists

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11583556

Modified cells and methods of therapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11582956

Recombinant adenovirus-based interferon biotherapeutics in swine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11583578

Plasmodium falciparum recombinanr xiexumapoeozoite protein compositions and method for vac

The Government of the United States, as represented by the Secretary of the Army · Granted Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11578315

Truncated guinea pig L-asparaginase variants and methods of use

United States Government as represented by the Department of Veterans Affairs · Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11578103

Nucleic acids encoding Zika virus-like particles and their use in Zika virus vaccines and

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11571444

Enhancement of MSC immunomodulatory properties by treprostinil

United Therapeutics Corporation · Granted Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11567073

Receptor tyrosine kinase biomarkers

United Kingdom Research and Innovation · Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11559565

Methods for treating inflammatory disorders and traumatic brain injury using stabilized no

United States Government as represented by the Department of Veterans Affairs · Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11560363

Synthesis of esuberaprost prodrugs

United Therapeutics Corporation · Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

US 11560559

Inducing production of full-length progranulin (GRN) from nucleotides including mutations

The United States as Represented by The Dept of Veteran Affairs (VA) · Granted Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)